BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 106 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $89,099 | -17.6% | 4,435 | +4.7% | 0.07% | -8.6% |
| Q2 2023 | $108,077 | +20.0% | 4,235 | 0.0% | 0.08% | +15.7% |
| Q1 2023 | $90,078 | -28.1% | 4,235 | 0.0% | 0.07% | -26.3% |
| Q4 2022 | $125,356 | +26.6% | 4,235 | 0.0% | 0.10% | +11.8% |
| Q3 2022 | $99,000 | +39.4% | 4,235 | 0.0% | 0.08% | +49.1% |
| Q2 2022 | $71,000 | -61.8% | 4,235 | 0.0% | 0.06% | -54.0% |
| Q1 2022 | $186,000 | -29.3% | 4,235 | -2.1% | 0.12% | -25.7% |
| Q4 2021 | $263,000 | +911.5% | 4,325 | +590.9% | 0.17% | +778.9% |
| Q3 2021 | $26,000 | – | 626 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |